Mateusz Kaczmarek

Mateusz Kaczmarek is a financial and technology journalist at TS2.tech, covering stocks, artificial intelligence, semiconductors and global market developments. A graduate of the Poznań University of Economics and Business, he previously worked in financial analysis before moving into business journalism. His reporting focuses on technology companies, market trends and the forces shaping global investment markets. Follow Mateusz Kaczmarek on Google News.

Sphere 3D Shares Surge 57% as Cathedra Merger Wraps Up

Sphere 3D Shares Surge 57% as Cathedra Merger Wraps Up

Sphere 3D Corp. shares surged roughly 57% in busy Nasdaq trading Monday after the bitcoin miner said it closed its merger with Cathedra Bitcoin. The companies said the deal will make for a bigger power-backed digital infrastructure business. The stock last traded at $2.99, down from a high of $4.32 earlier, with more than 55 million shares changing hands.
1 June 2026
··
GrowHub Shares Pop After EnChem Filing, Investors Weigh Dilution

GrowHub Shares Pop After EnChem Filing, Investors Weigh Dilution

GrowHub Ltd shares jumped in Monday morning trading on Nasdaq, after the Singapore-based traceability tech firm said it signed a binding term sheet to hand control of the listed shell to EnChem America, which makes battery-electrolyte materials. Shares last traded at $2.23, climbing about 541% from the last close at $0.3478, after hitting $2.95 earlier on volume of roughly 88.5 million shares.
1 June 2026
·
HPE Shares Push Higher Ahead of Earnings as AI Server Demand Looks Broader

HPE Shares Push Higher Ahead of Earnings as AI Server Demand Looks Broader

Hewlett Packard Enterprise shares were pointed up 5.1% to $45.27 in premarket trading at 8:54 a.m. Eastern on Monday, set for another jump as investors looked ahead to the company’s quarterly numbers coming after the bell. The move follows a Friday close at $43.07 and comes as the company’s new Nvidia-based server draw attention.
1 June 2026
·······
Revolution Medicines Stock Moves Premarket After Pancreatic Cancer Data

Revolution Medicines Stock Moves Premarket After Pancreatic Cancer Data

Revolution Medicines Inc shares gained in early U.S. premarket trading Monday after late-stage trial results reported its experimental pill for pancreatic cancer almost doubled survival against chemo. RVMD was last seen at $157.48, up $2.93, or 1.9%, ahead of the regular Nasdaq open. The company’s market cap hovered at about $31.2 billion. Nasdaq’s 2026 calendar does not list June 1 as a holiday—Memorial Day shows May 25 and Juneteenth June 19 as closures.
1 June 2026
···
Marvell Shares Face Monday Test After AI-Driven Climb

Marvell Shares Face Monday Test After AI-Driven Climb

Marvell Technology is set to open Monday trading close to the highs it reached in a strong 2026 stretch, as last week’s results pushed some investors to buy up the chipmaker on hopes for more artificial-intelligence revenue, though some remained cautious. The Nasdaq-listed shares finished Friday at $205.00, a gain of 0.08% for the session and roughly 4.4% above the previous Friday’s $196.33 close. Nasdaq is closed Sunday and trades between 9:30 a.m. and 4 p.m. ET on weekdays.
1 June 2026
···
1 … 21 22 23 24 25 … 164

Stock Market Today

  • Passive Income: FTSE 100 Stocks Set to Go Ex-Dividend in August
    July 25, 2026, 2:56 AM EDT. BT Group, Imperial Brands, and Investec-three leading FTSE 100 firms-are scheduled to go ex-dividend in August, featuring attractive dividend yields of 4.4%, 6%, and 6.6%, respectively. BT Group is set to pay 5.78p/share on August 6, with Imperial Brands paying almost 42p/share and Investec 21p/share, both by August 20. These shares offer passive income opportunities alongside relatively low P/E ratios of 10, 8, and another low figure, indicating market caution but also potential value.